Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
41
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

Fu-Chao Ma1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Qian Yu1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Zhi-Ming Zeng1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Rong-Quan He1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Chao-Hua Mo2 Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
,
Jin-Cai Zhong1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Jie Ma1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning
,
Zhen-Bo Feng2 Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
,
Gang Chen2 Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China
&
Xiao-Hua Hu1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, NanningCorrespondence[email protected]
 show all
Pages 5237-5242 | Published online: 01 Nov 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yubin Hu, Hailan Lin, Mingzhi Hao, Yan Zhou, Qizhong Chen & Zhangxian Chen. (2020) Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study. Cancer Management and Research 12, pages 5345-5351.
Read now

Articles from other publishers (3)

Yufei Liu, Shuyu Hao, Nan Ji, Jiangfei Wang & Liwei Zhang. (2020) Combination of Anti–Programmed Death 1 Therapy and Apatinib for a Patient with Hepatocellular Carcinoma and Brain Metastasis: Case Report and Literature Review. World Neurosurgery 143, pages 114-117.
Crossref
Manping Huang, Bin Huang, Guowen Li & Sainan Zeng. (2018) Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell. BMC Gastroenterology 18:1.
Crossref
. (2017) Apatinib/gemcitabine/paclitaxel. Reactions Weekly 1682:1, pages 47-47.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.